|
Volumn 34, Issue 6, 2003, Pages
|
Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GELATINASE A;
GELATINASE B;
TISSUE PLASMINOGEN ACTIVATOR;
UROKINASE;
ACUTE DISEASE;
ADULT;
AGED;
ARTICLE;
BLOOD;
BRAIN HEMORRHAGE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ADMINISTRATION ROUTE;
DRUG EFFECT;
DRUG RESISTANCE;
ENZYMOLOGY;
FEMALE;
FIBRINOLYTIC THERAPY;
HUMAN;
MALE;
MIDDLE AGED;
PREDICTION AND FORECASTING;
PROSPECTIVE STUDY;
REFERENCE VALUE;
RISK FACTOR;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VASCULAR PATENCY;
ACUTE DISEASE;
ADULT;
AGED;
AGED, 80 AND OVER;
CEREBRAL HEMORRHAGE;
CEREBROVASCULAR ACCIDENT;
DRUG ADMINISTRATION ROUTES;
DRUG RESISTANCE;
FEMALE;
HUMANS;
MALE;
MATRIX METALLOPROTEINASE 2;
MATRIX METALLOPROTEINASE 9;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
PROSPECTIVE STUDIES;
REFERENCE VALUES;
RISK FACTORS;
THROMBOLYTIC THERAPY;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT FAILURE;
TREATMENT OUTCOME;
URINARY PLASMINOGEN ACTIVATOR;
VASCULAR PATENCY;
MLCS;
MLOWN;
|
EID: 0038003748
PISSN: None
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/01.str.0000073788.81170.1c Document Type: Article |
Times cited : (57)
|
References (0)
|